In this issue of Neuron, Ishiguro et al. (2017) explore the toxicity of RAN translation in spinocerebellar ataxia 31. Using a Drosophila model, the authors demonstrate that TDP-43 and other RNA-binding proteins act as chaperones to regulate the formation of toxic RNA aggregates.
SCA31 is an inherited form of ataxia caused by expansion of a UGGAA repeat. Ishiguro et al. (2017) identified proteins associated with other neurological diseases as binding partners of UGGAA repeats. Using a fly model, they show that TDP-43 and other RNA-binding proteins act as chaperones to regulate the formation of toxic RNA aggregates. The model showcases a reciprocal relationship between RNA repeat expansions and RNA-binding proteins that may be pathogenic in SCA31 and other neurological disorders.
The prevailing view two decades ago was that repeat expansion disorders were clearly divided between those that were translated, e.g., Huntington disease, thus creating toxic proteins, and those that are not translated and thus exert toxicity as RNA species (e.g., myotonic dystrophy; La Spada and Taylor, 2010) . More recently, this dogma has come into question with the discovery of repeat-associated, non-AUG (RAN) translation associated with C9orf72a (Cleary and Ranum, 2014) . Repeat expansions in C9orf72a are associated with inherited forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); recent observations of chorea and parkinsonism associated with expanded repeat C9orf72a appears to suggest that the phenotypic spectrum of disease may be bewilderingly wide (Baizabal-Carvallo and Jankovic, 2016) .
The report in this issue of Neuron (Ishiguro et al., 2017) focuses on a repeat expansion disorder that is one of the most prevalent causes of autosomal dominant cerebellar ataxia in Japan, spinocerebellar ataxia 31 (SCA31), in order to explore the toxicity of RAN translation. In SCA31, a pentanucleotide repeat expansion gives rise to toxic UGGAA repeats, which are translated as poly-WNGME proteins. Ishiguro et al. (2017) engineered flies that could express various lengths of UGGAA repeats in the eye or nervous system. These were then used to test interactions with various RNA-binding proteins that were identified using RNA pulldown experiments designed to find expanded UGGAAbinding partners.
It is perhaps too easy to over interpret genetic interaction experiments using expanded repeat toxicity in the fly eye, but Ishiguro et al. (2017) steer clear of that, instead focusing on what these models do best: quickly and cleanly assessing enhancer and suppressor interactions, making use of multiple repeat lengths, as well as RNA-binding proteins with mutations and deletions in various motifs. Of note, the binding partners identified in the screen include those associated with inherited causes of ALS and FTD, including TAR DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS; Ling et al., 2013) .
TDP-43 has been reported to play many roles in RNA regulation, and Ishiguro et al. (2017) of the Neuron report use their facile SCA31 model to hone in on the UGGAA interaction with TDP-43. What emerges is a sort of yin yang relationship in which TDP-43 can play a toxic role on its own but protective roles with expanded repeats. TDP-43 interacts directly with UGGAA in bandshift assays. While misexpression of human TDP-43 alone in the eye produces a ''rough eye'' phenotype, this is much less severe than the expanded UGGAA phenotype; surprisingly, when TDP-43 is co-expressed with expanded UGGAA, it actually suppresses the RNA-mediated rough eye. Deletion analysis reveals that this requires the RNA recognition motif of TDP-43.
While analysis of expanded repeat RNA and protein conformation in Drosophila tissues has inherent limitations, TDP-43 suppressed the formation of RNA foci associated with AGGAA expansion in larval eye tissue, producing smaller and more granular foci, but did not appear to cause degradation of transcripts. The interaction was also probed at much higher resolution using atomic force microscopy (AFM). Here, a C-terminal truncated recombinant TDP-43 construct was used to analyze RNA, as full-length TDP-43 alone is more aggregation prone. UGGAA RNA species rapidly aggregated at room temperature; co-incubation with truncated TDP-43 inhibited this aggregation in an ATP-independent fashion, consistent with the definition of an RNA chaperone. Ishiguro et al. (2017) then proceed to explore the interaction of TDP-43 with SCA31 at the protein level. Pentapeptide repeats are expressed in Drosophila tissue and SCA31 brain, and TDP-43 co-expression with expanded UGGAA in the fly markedly inhibits expression of protein as assessed using a new affinity-purified anti-pentapeptide antibody. This TDP-43-mediated inhibition of repeat protein does not require the RNA recognition motif. Ishiguro et al. (2017) go on to show that FUS and another RNA-binding protein play similar protective roles by suppressing RNA aggregation despite having mild eye phenotypes themselves. Do these RNA-binding proteins indeed play a protective role as RNA chaperones in SCA31 or c9orf72a patient brains? If so, exactly how do they influence RNA folding? And to what extent does aberrant RNA chaperone activity play a role in neurodegeneration associated with ALS or FTD in patients with TDP-43 or FUS mutations? These questions remain to be answered, and fly models can only take us so far in these efforts. Nonetheless, they have given a tour de force performance in this particular paradigm to highlight a likely important function of these proteins in RNA regulation.
